Equities

Krynica Vitamin SA

KVT:WSE

Krynica Vitamin SA

Actions
Consumer Staples Beverages
  • Price (PLN)9.70
  • Today's Change0.08 / 0.83%
  • Shares traded255.00
  • 1 Year change-29.20%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2.470.772.08
Total Receivables, Net495055
Total Inventory414233
Prepaid expenses------
Other current assets, total--0.00--
Total current assets939391
Property, plant & equipment, net130133129
Goodwill, net------
Intangibles, net2.002.372.79
Long term investments------
Note receivable - long term------
Other long term assets0.000.00--
Total assets228233227
LIABILITIES
Accounts payable715972
Accrued expenses2.081.882.13
Notes payable/short-term debt3.926.562.61
Current portion long-term debt/capital leases383527
Other current liabilities, total2.464.015.45
Total current liabilities118106109
Total long term debt151820
Total debt576050
Deferred income tax2.343.844.95
Minority interest------
Other liabilities, total111415
Total liabilities146142149
SHAREHOLDERS EQUITY
Common stock181818
Additional paid-in capital------
Retained earnings (accumulated deficit)637359
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity829178
Total liabilities & shareholders' equity228233227
Total common shares outstanding121212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.